Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ann Marie Vande More"'
Autor:
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, Camille Esneau, Mariana Ruiz Silva, Timothy Ison, Christina Fichter, Joseph A. Lopez, Deborah Chandra, Zin Naing, Joanna Caguicla, Daiyang Li, Gregory Walker, Supavadee Amatayakul-Chantler, Nathan Roth, Sandro Manni, Thomas Hauser, Thomas Barnes, Anna Condylios, Malinna Yeang, Maureen Wong, Charles S.P. Foster, Kenta Sato, Sharon Lee, Yang Song, Lijun Mao, Allison Sigmund, Amy Phu, Ann Marie Vande More, Stephanie Hunt, Mark Douglas, Ian Caterson, Warwick Britton, Kerrie Sandgren, Rowena Bull, Andrew Lloyd, Jamie Triccas, Stuart Tangye, Nathan W. Bartlett, David Darley, Gail Matthews, Damien J. Stark, Kathy Petoumenos, William D. Rawlinson, Ben Murrell, Fabienne Brilot, Anthony L. Cunningham, Anthony D. Kelleher, Anupriya Aggarwal, Stuart G. Turville
Publikováno v:
EBioMedicine, Vol 90, Iss , Pp 104545- (2023)
Summary: Background: The Omicron era of the COVID-19 pandemic commenced at the beginning of 2022 and whilst it started with primarily BA.1, it was latter dominated by BA.2 and the related sub-lineage BA.5. Following resolution of the global BA.5 wave
Externí odkaz:
https://doaj.org/article/c20ddc7898f64d7197436749654ce9c9
Autor:
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, Camille Esneau, Mariana Ruiz Silva, Timothy Ison, Christina Fitcher, Joseph A Lopez, Deborah Chandra, Zin Naing, Joanna Caguicla, Daiyang Li, Gregory Walker, Supavadee Amatayakul-Chantler, Nathan Roth, Sandro Manni, Thomas Hauser, Thomas Barnes, Anna Condylios, Malinna Yeang, Maureen Wong, Charles S.P. Foster, Kenta Sato, Sharon Lee, Yang Song, Lijun Mao, Allison Sigmund, Amy Phu, Ann Marie Vande More, Stephanie Hunt, Mark Douglas, Ian Caterson, Kerrie Sandgren, Rowena Bull, Andrew Lloyd, Jamie Triccas, Stuart Tangye, Nathan W Bartlett, David Darley, Gail Matthews, Damien J. Stark, William D. Rawlinson, Ben Murrell, Fabienne Brilot, Anthony L Cunningham, Anthony D. Kelleher, Anupriya Aggarwal, Stuart G. Turville
The Omicron era of the COVID-19 pandemic commenced at the beginning of 2022 and whilst it started with primarily BA.1, it was latter dominated by BA.2 and related sub-lineages. Over the course of 2022, we monitored the potency and breadth of antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a1af66d5a7407e69d445089139a254f
https://doi.org/10.1101/2022.12.06.22283000
https://doi.org/10.1101/2022.12.06.22283000
Autor:
Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, Camille Esneu, Mariana Ruiz Silva, Timothy Ison, Christina Fitcher, Joseph A. Lopez, Deborah Chandra, Zin Naing, Joanna Caguicla, Daiyang Li, Gregory Walker, Supavadee Amatayakul-Chantler, Nathan Roth, Sandro Manni, Thomas Hauser, Thomas Barnes, Anna Condylios, Malinna Yeang, Maureen Wong, Charles Foster, Sharon Lee, Yang Song, Lijun Mao, Allison Sigmund, Amy Phu, Ann Marie Vande More, Stephanie Hunt, Mark Douglas, Ian Caterson, Kerrie J. Sandgren, Rowena Anne Bull, Andrew R. Lloyd, Jamie Triccas, Stuart G. Tangye, Nathan Wylie Bartlett, David R. Darley, Gail Matthews, Damian Starck, William Rawlinson, Fabienne Brilot, Anthony L. Cunningham, Anthony Kelleher, Anupriya Aggarwal, Stuart Turville
Publikováno v:
SSRN Electronic Journal.